研究报告 |
|
|
|
|
人Nek2蛋白原核表达纯化及其多克隆抗体制备 * |
陈秋利1,杨丽超1,李辉1,温莎1,李刚1,何敏1,2,**() |
1 广西医科大学公共卫生学院 南宁 530000 2 广西医科大学实验动物中心 南宁 530000 |
|
Prokaryotic Expression,Purification and Preparation of Polyclonal Antibody of Human Nek2 Protein |
CHEN Qiu-li1,YANG Li-chao1,LI Hui1,WEN Sha1,LI Gang1,HE Min1,2,**() |
1 School of Public Health Guangxi Medical University, Nanning 530000,China 2 Guangxi Medical University Laboratory Animal Center,Nanning 530000,China |
引用本文:
陈秋利,杨丽超,李辉,温莎,李刚,何敏. 人Nek2蛋白原核表达纯化及其多克隆抗体制备 *[J]. 中国生物工程杂志, 2020, 40(3): 31-37.
CHEN Qiu-li,YANG Li-chao,LI Hui,WEN Sha,LI Gang,HE Min. Prokaryotic Expression,Purification and Preparation of Polyclonal Antibody of Human Nek2 Protein. China Biotechnology, 2020, 40(3): 31-37.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.1908061
或
https://manu60.magtech.com.cn/biotech/CN/Y2020/V40/I3/31
|
[1] |
Fry A M, Meraldi P, Nigg E A . A centrosomal function for the human Nek2 protein kinase, a member of the NIMA family of cell cycle regulators. Embo Journal, 1998,17(2):470-481.
|
[2] |
Federica B, Paronetto M P, Renato F , et al. Increased expression and nuclear localization of the centrosomal kinase Nek2 in human testicular seminomas. Journal of Pathology, 2010,217(3):431-441.
|
[3] |
Tong H, Wang J, Chen H , et al. Transcriptomic analysis of gene expression profiles of stomach carcinoma reveal abnormal expression of mitotic components. Life Sciences, 2016,170:41-49.
|
[4] |
Liu H, Liu B, Hou X , et al. Overexpression of NIMA-related kinase 2 is associated with poor prognoses in malignant glioma. Journal of Neuro-oncology, 2017,132(3):1-9.
|
[5] |
Shi Y X, Yin J Y, Shen Y , et al. Genome-scale analysis identifies NEK2, DLGAP5 and ECT2 as promising diagnostic and prognostic biomarkers in human lung cancer. Scientific Reports, 2017,7(1):8072.
|
[6] |
成金俊 . 淫羊藿苷单克隆抗体的制备及其ELISA法的建立和FLISA法的初探. 北京:北京中医药大学, 2015.
|
|
Cheng J J . Preparation of monoclonal antibody against icariin and establishment of ELISA method and preliminary study of FLISA method. Beijing:Beijing University of Chinese Medicine, 2015.
|
[7] |
Long X, Gou Y, Luo M , et al. Soluble expression, purification, and characterization of active recombinant human tissue plasminogen activator by auto-induction in E. coli. Bmc Biotechnology, 2015,15(1):1-9.
|
[8] |
杨隆兵, 国果, 马慧玲 , 等. 家蝇抗菌肽AMPs17蛋白原核表达条件的优化及其抗真菌活性检测. 中国生物工程杂志, 2019,39(4):24-31.
|
|
Yang L B, Guo G, Ma H L , et al. Optimization of prokaryotic expression conditions and antifungal activity detection of antibacterial peptide AMPs17 protein in Musca domestica. China Biotechnology, 2019,39(4):24-31.
|
[9] |
张婷婷, 叶波平 . 包涵体蛋白质的复性研究进展. 药物生物技术, 2007,14(4):306-309.
|
|
Zhang T T, Ye B P . Advances in research on renaturation of inclusion body proteins. Pharmaceutical Biotechnology, 2007,14(4):306-309.
|
[10] |
高慎阳, 查恩辉, 王珅 , 等. 一种"高性价比"切胶纯化原核表达蛋白的方法. 中国农学通报, 2010,26(22):24-26.
|
|
Gao S Y, Zha E H, Wang K , et al. A"cost-effective"method for purification of prokaryotic expression proteins in gel slices. Chinese Agricultural Science Bulletin, 2010,26(22):24-26.
|
[11] |
Jiang X, Xia S, He X , et al. Targeting peptide-enhanced antibody and CD11c+ dendritic cells to inclusion bodies expressing protective antigen against ETEC in mice. The FASEB Journal, 2019,33(2):2836-2847.
|
[12] |
陈云雨, 牛夏忆, 李淼 , 等. 大肠杆菌FtsZ蛋白原核表达及多克隆抗体的制备与鉴定. 生物工程学报, 2019,35(8):1-10.
|
|
Chen Y Y, Niu X Y, Li M , et al. Bacterial expression, preparation and identification of polyclonal antibody against Escherichia coli FtsZ. Chin J Biotech, 2019,35(8):1-10.
|
[13] |
林双 . NEK2在原发性肝细胞肝癌中的表达及对其生物学特性的影响. 杭州:浙江大学, 2017.
|
|
Lin S . The expression of NEK2 in hepatocellular carcinoma and its effect on the biological characteristics. Hangzhou:Zhejiang University, 2017.
|
[14] |
Li G, Zhong Y, Shen Q , et al. NEK2 serves as a prognostic biomarker for hepatocellular carcinoma. International Journal of Oncology, 2017,50(2):405-413.
|
[15] |
Kokuryo T, Hibino S, Suzuki K , et al. Nek2 siRNA therapy using a portal venous port-catheter system for liver metastasis in pancreatic cancer. Cancer Science, 2016,107(9):1315-1320.
|
[16] |
Hu C M, Zhu J, Guo X E , et al. Novel small molecules disrupting Hec1/Nek2 interaction ablate tumor progression by triggering Nek2 degradation through a death-trap mechanism. Oncogene, 2014,34(10):1220-1230.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|